US › Healthcare

Spok Holdings Inc (SPOK)

US · Healthcare · Health Information Services

$11.21+0.99%
Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue
$35.0M
Revenue YoY
-1.9%
Net profit
$4.1M
Profit YoY
-9.5%
EPS
$0.20
EPS estimate
$0.15
Net margin
11.8%

EPS came in at 0.20 against a street estimate of 0.15 — a beat of 33.3%.

Key statistics

Market cap
$228.0M
P/E
19.1
Forward P/E
10.2
P/B
1.63
Book value
$6.75
EPS (TTM)
$0.57
Dividend yield
11.63%
52-week high
$17.04
52-week low
$9.66
50-day MA
$10.64
200-day MA
$12.24
Beta
0.45

Analyst view

Analysts rate Spok Holdings Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $14.00.

Shareholding

Insiders
2.40%
Institutions
56.17%

Largest institutional holders

FundStake
BlackRock Inc8.01%
Renaissance Technologies Corp6.03%
Vanguard Capital Management, LLC4.11%
Dimensional Fund Advisors, Inc.3.42%
Geode Capital Management, LLC2.61%
State Street Corp2.21%
HighTower Advisors, LLC1.83%
Vanguard Portfolio Management, LLC1.27%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Spok Holdings Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.